| 1.63 -0.01 (-0.61%) | 07-26 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |   |
|||
| Targets | 6-month : | 2.74 | 1-year : | 3.36 |
| Resists | First : | 2.35 | Second : | 2.88 |
| Pivot price | 2.07  |
|||
| Supports | First : | 1.5 | Second : | 1.24 |
| MAs | MA(5) : | 1.78 |
MA(20) : | 2.11 |
| MA(100) : | 3.97 |
MA(250) : | 12.95 |
|
| MACD | MACD : | -0.3 |
Signal : | -0.3 |
| %K %D | K(14,3) : | 10 |
D(3) : | 10.3 |
| RSI | RSI(14): 30.3 |
|||
| 52-week | High : | 42 | Low : | 1.5 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ AKAN ] has closed above bottom band by 4.3%. Bollinger Bands are 68.1% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 31 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 1.71 - 1.72 | 1.72 - 1.73 |
| Low: | 1.6 - 1.61 | 1.61 - 1.62 |
| Close: | 1.62 - 1.63 | 1.63 - 1.64 |
Akanda Corp., through its subsidiaries, engages in the cultivation, manufacture, and distribution of cannabis products in the United Kingdom, Lesotho, and internationally. It intends to supply cannabis based medical and wellness products. The company was incorporated in 2021 and is headquartered in New Romney, the United Kingdom.
Fri, 26 Jul 2024
Akanda Corp. (NASDAQ:AKAN) Short Interest Up 100.2% in July - Defense World
Sat, 13 Jul 2024
Akanda Corp. (NASDAQ:AKAN) Short Interest Down 50.3% in June - American Banking and Market News
Fri, 14 Jun 2024
Akanda Corporation Announces Completion of F-3 Shelf Registration Statement - StockTitan
Fri, 24 May 2024
What's Going On With Medical Cannabis Company Akanda Stock Friday? - Benzinga
Fri, 24 May 2024
Why Is Akanda (AKAN) Stock Up 133% Today? - InvestorPlace
Thu, 23 May 2024
Akanda Corp Announces Reverse Stock Split - TipRanks
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Drug Manufacturers - Specialty & Generic
|
|
| Shares Out | 2 (M) |
| Shares Float | 1 (M) |
| Held by Insiders | 2.1 (%) |
| Held by Institutions | 0.2 (%) |
| Shares Short | 43 (K) |
| Shares Short P.Month | 57 (K) |
| EPS | -286.4 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | -27.21 |
| Profit Margin | 0 % |
| Operating Margin | -522 % |
| Return on Assets (ttm) | -25.7 % |
| Return on Equity (ttm) | -279.8 % |
| Qtrly Rev. Growth | -70.1 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 1.12 |
| EBITDA (p.s.) | -2.99 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -2 (M) |
| Levered Free Cash Flow | 1 (M) |
| PE Ratio | -0.01 |
| PEG Ratio | 0 |
| Price to Book value | -0.06 |
| Price to Sales | 1.44 |
| Price to Cash Flow | -2.09 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|